on VALBIOTIS (EPA:ALVAL)
Valbiotis General Meeting Approves All Resolutions
On April 17, 2026, Valbiotis held its Combined General Meeting in La Rochelle, chaired by Sebastien Peltier. During the meeting, all proposed resolutions were approved by a broad majority of shareholders. Notably, Resolutions 7, 8, and 9 concerning Supervisory Board appointments were passed.
Agnès Tixier’s term as an independent member was renewed. Additionally, two new members joined the board to enhance the company’s expertise in supporting its commercial expansion. Patricia Tranvouëz, with over 30 years of marketing and executive experience, and Laurent Keiser, with extensive experience in pharmacy distribution, were selected for their strategic insight and operational prowess.
Shareholders benefit from a 20% discount on Valbiotis products by providing proof of ownership of at least 85 shares.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news